5‐Alpha reductase inhibitors induce a prostate luminal to club cell transition in human benign prostatic hyperplasia-Reference-Cited by-同舟云学术

5‐Alpha reductase inhibitors induce a prostate luminal to club cell transition in human benign prostatic hyperplasia

Published:2022-02-03 Issue: Volume: Page:
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:The Journal of Pathology

Author:

Joseph Diya B¹^ORCID,Henry Gervaise H¹^ORCID,Malewska Alicia¹^ORCID,Reese Jeffrey C²,Mauck Ryan J¹^ORCID,Gahan Jeffrey C¹^ORCID,Hutchinson Ryan C¹^ORCID,Mohler James L³^ORCID,Roehrborn Claus G¹^ORCID,Strand Douglas W¹^ORCID

Affiliation:

1. Department of Urology UT Southwestern Medical Center Dallas TX 75390 USA

2. Southwest Transplant Alliance Dallas TX USA

3. Roswell Park Comprehensive Cancer Center Buffalo NY USA

Funder

American Urological Association Foundation

National Cancer Institute

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.5857

Reference36 articles.

1. Targeting phenotypic heterogeneity in benign prostatic hyperplasia

2. The Effect of Finasteride in Men with Benign Prostatic Hyperplasia

3. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia

4. Origin and evolution of benign prostatic enlargement;McNeal JE;Invest Urol,1978

5. A Cellular Anatomy of the Normal Adult Human Prostate and Prostatic Urethra

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishing and Characterizing the Molecular Profiles, Cellular Features, and Clinical Utility of a Patient-Derived Xenograft Model Using Benign Prostatic Tissues;Laboratory Investigation;2024-10

2. Analysis of environmental pollutant Bisphenol F elicited prostate injury targets and underlying mechanisms through network toxicology, molecular docking, and multi-level bioinformatics data integration;Toxicology;2024-08

3. Network pharmacology and experimental validation to explore the pharmacological mechanism of saw palmetto and its core ingredients in benign prostatic hyperplasia treatment;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-17

4. Deep phenotyping of the prostate tumor microenvironment reveals molecular stratifiers of relapse linked to inflammatory chemokine expression and aberrant metabolism;2024-05-15

5. Integrating spatial transcriptomics and single-cell RNA-sequencing reveals the alterations in epithelial cells during nodular formation in benign prostatic hyperplasia;Journal of Translational Medicine;2024-04-23